Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Cryosupernatant and Immunosuppression as Effective Alternative Therapies for TTP in Three Pediatric SLE Patients

Authors: Pragathesh Palaniappan, Arul Premanand Lionel, Indira Agarwal, Sarah Mathai, Leni Mathew, Sanwar Agarwal, Purva Keni, Raju Khubchandani, Sathish Kumar

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Thrombotic thrombocytopenic purpura (TTP) and systemic lupus erythematosus (SLE) very rarely present simultaneously and pose a diagnostic and therapeutic dilemma to the physician. Prompt diagnosis and management with plasma exchange and immunosuppression is life-saving. To describe the effectiveness of cryosupernatant and steroids in pediatric SLE with TTP. We describe three children aged 12–14 years with SLE who were diagnosed with TTP based on fever, CNS manifestations, ANA, anti-dsDNA, anti-sm positivity, hypocomplementemia, and microangiopathic anemia with thrombocytopenia. All three children were managed with cryosupernatant and steroids without plasmapheresis. All children improved with cryosupernatant and steroids. All attained remission within 10 days. They were doing well at last follow up without relapse or flare. Cryosupernatant and steroids may be an effective therapy for Thrombotic thrombocytopenic purpura with systemic lupus erythematosus
Literature
1.
go back to reference Kwok SK, Ju JH, Cho CS, Kim HY, Park SH (2009) Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus 18:16–21PubMedCrossRef Kwok SK, Ju JH, Cho CS, Kim HY, Park SH (2009) Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus 18:16–21PubMedCrossRef
2.
go back to reference Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh Y et al (2003) Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 22:355–358PubMedCrossRef Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh Y et al (2003) Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 22:355–358PubMedCrossRef
3.
go back to reference Kiss JE (2010) Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol 91:36–45PubMedCrossRef Kiss JE (2010) Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol 91:36–45PubMedCrossRef
4.
go back to reference Brunner HI, Freedman M, Silverman ED (1999) Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 42:2346–2355PubMedCrossRef Brunner HI, Freedman M, Silverman ED (1999) Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 42:2346–2355PubMedCrossRef
5.
go back to reference Musio F, Bohen EM, Yuan CM, Welch PG (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28:1–19PubMedCrossRef Musio F, Bohen EM, Yuan CM, Welch PG (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28:1–19PubMedCrossRef
6.
go back to reference Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397PubMedCrossRef Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397PubMedCrossRef
7.
go back to reference Altuntas F, Aydogdu I, Kabukcu S et al (2007) Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci 36:57–67PubMedCrossRef Altuntas F, Aydogdu I, Kabukcu S et al (2007) Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci 36:57–67PubMedCrossRef
8.
go back to reference Muscal E, Edwards RM, Kearney DL, Hicks JM, Myones BL, Teruya J (2011) Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus. Am J Clin Pathol 135:406–416PubMedCrossRef Muscal E, Edwards RM, Kearney DL, Hicks JM, Myones BL, Teruya J (2011) Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus. Am J Clin Pathol 135:406–416PubMedCrossRef
9.
go back to reference Rock G, Anderson D, Clark W, Leblond P, Palmer D, Sternbach M et al (2005) Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. Br J Haematol. 129:79–86CrossRef Rock G, Anderson D, Clark W, Leblond P, Palmer D, Sternbach M et al (2005) Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. Br J Haematol. 129:79–86CrossRef
10.
go back to reference Allford SL, Hunt BJ, Rose P (2003) Machin SJ; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic hemolytic anaemias. Br J Haematol 120:556–573PubMedCrossRef Allford SL, Hunt BJ, Rose P (2003) Machin SJ; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic hemolytic anaemias. Br J Haematol 120:556–573PubMedCrossRef
11.
go back to reference Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC (2009) Interventions for hemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 1:CD003595PubMed Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC (2009) Interventions for hemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 1:CD003595PubMed
12.
go back to reference Scully M, Longair I, Flynn M, Berryman J, Machin SJ (2007) Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang 93:154–158PubMedCrossRef Scully M, Longair I, Flynn M, Berryman J, Machin SJ (2007) Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang 93:154–158PubMedCrossRef
13.
go back to reference Cacoub P, Limal N, Sène D, Guichard I, Piette JC (2008) Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Lupus 17:69–71PubMedCrossRef Cacoub P, Limal N, Sène D, Guichard I, Piette JC (2008) Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Lupus 17:69–71PubMedCrossRef
14.
go back to reference Shah AA, Higgins JP, Chakravarty EF (2007) Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat Clin Pract Rheumatol 3:357–362PubMedCrossRef Shah AA, Higgins JP, Chakravarty EF (2007) Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat Clin Pract Rheumatol 3:357–362PubMedCrossRef
Metadata
Title
Cryosupernatant and Immunosuppression as Effective Alternative Therapies for TTP in Three Pediatric SLE Patients
Authors
Pragathesh Palaniappan
Arul Premanand Lionel
Indira Agarwal
Sarah Mathai
Leni Mathew
Sanwar Agarwal
Purva Keni
Raju Khubchandani
Sathish Kumar
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0338-8

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine